{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T14:49:20Z","timestamp":1761662960491},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2011,5,19]],"date-time":"2011-05-19T00:00:00Z","timestamp":1305763200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["BMC Public Health"],"published-print":{"date-parts":[[2011,12]]},"DOI":"10.1186\/1471-2458-11-351","type":"journal-article","created":{"date-parts":[[2011,5,20]],"date-time":"2011-05-20T06:15:57Z","timestamp":1305872157000},"source":"Crossref","is-referenced-by-count":21,"title":["A hepatitis A, B, C and HIV prevalence and risk factor study in ever injecting and non-injecting drug users in Luxembourg associated with HAV and HBV immunisations"],"prefix":"10.1186","volume":"11","author":[{"given":"Nathalie","family":"Removille","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alain","family":"Origer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sophie","family":"Couffignal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michel","family":"Vaillant","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean-Claude","family":"Schmit","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marie-Lise","family":"Lair","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2011,5,19]]},"reference":[{"key":"3180_CR1","unstructured":"European Monitoring Centre for Drugs and Drug Addiction (EMCDDA): Annual report 2003. The state of the drugs problem in the European Union and Norway. . Lisbon"},{"key":"3180_CR2","unstructured":"2010 Annual report on the state of the drugs problem in Europe. . 2010, European Monitoring Centre for Drugs and Drug Addiction (EMCDDA), Lisbon"},{"key":"3180_CR3","unstructured":"European Monitoring Centre for Drugs and Drug Addiction (EMCDDA): Annual report 2005. The state of the drugs problem in Europe. . Lisbon"},{"issue":"1","key":"3180_CR4","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1086\/375566","volume":"37","author":"G Quaglio","year":"2003","unstructured":"Quaglio G, Lugoboni F, Pajusco B, Sarti M, Talamini G, Lechi A, Mezzelani P, Des Jarlais DC: Factors associated with hepatitis C virus infection in injection and noninjection drug users in Italy. Clin Infect Dis. 2003, 37 (1): 33-40. 10.1086\/375566.","journal-title":"Clin Infect Dis"},{"key":"3180_CR5","doi-asserted-by":"crossref","unstructured":"Camoni L, Regine V, Salfa MC, Nicoletti G, Canuzzi P, Magliocchetti N, Rezza G, Suligoi B: Continued high prevalence of HIV, HBV and HCV among injecting and noninjecting drug users in Italy. Ann Ist Super Sanita. 46 (1): 59-65.","DOI":"10.1590\/S0021-25712010000100008"},{"issue":"6","key":"3180_CR6","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1023\/A:1007410707801","volume":"14","author":"MLMG Otilia Evora Santana Rodr\u00edguez","year":"1998","unstructured":"Otilia Evora Santana Rodr\u00edguez MLMG, Juan Francisco Hern\u00e1ndez Santana, Jos\u00e9 Mar\u00eda Limi\u00f1ana Ca\u00f1al, Antonio Manuel Mart\u00edn S\u00e1nchez: Prevalence of Serologic Markers of HBV, HDV, HCV and HIV in Non-Injection Drug Users Compared to Injection Drug Users in Gran Canaria, Spain. European journal of epidemiology. 1998, 14 (6): 555-561. 10.1023\/A:1007410707801.","journal-title":"European journal of epidemiology"},{"key":"3180_CR7","volume-title":"Luxembourg: Centre P\u00e9nitentiaire Luxembourg","author":"J Schlink","year":"1999","unstructured":"Schlink J: Etude \u00e9pid\u00e9miologique des infections \u00e0 HIV et \u00e0 l'h\u00e9patite virale C dans les prisons luxembourgeoises. Luxembourg: Centre P\u00e9nitentiaire Luxembourg. 1999"},{"key":"3180_CR8","volume-title":"R\u00e9seau National d'Information sur les Stup\u00e9fiants et les Toxicomanies (R.E.L.I.S)","author":"A Origer","year":"2005","unstructured":"Origer A: L'\u00e9tat du ph\u00e9nom\u00e8ne de la drogue au Grand-Duch\u00e9 de Luxembourg. R\u00e9seau National d'Information sur les Stup\u00e9fiants et les Toxicomanies (R.E.L.I.S). ed.2005. Luxembourg. . 2005, Point focal OEDT Luxembourg - CRP-Sant\u00e9"},{"issue":"55","key":"3180_CR9","first-page":"53","volume":"1-2","author":"LR Hartnoll","year":"2003","unstructured":"Hartnoll LR: Drug epidemiology in the European institutions: historical background and key indicators. Bulletin on Narcotics. 2003, 1-2 (55): 53-71.","journal-title":"Bulletin on Narcotics"},{"issue":"2","key":"3180_CR10","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1053\/jinf.2000.0647","volume":"40","author":"A Taylor","year":"2000","unstructured":"Taylor A, Goldberg D, Hutchinson S, Cameron S, Gore SM, McMenamin J, Green S, Pithie A, Fox R: Prevalence of hepatitis C virus infection among injecting drug users in Glasgow 1990-1996: are current harm reduction strategies working?. The Journal of infection. 2000, 40 (2): 176-183. 10.1053\/jinf.2000.0647.","journal-title":"The Journal of infection"},{"key":"3180_CR11","volume-title":"R\u00e9seau National d'Information sur les Stup\u00e9fiants et les Toxicomanies (R.E.L.I.S)","author":"A Origer","year":"2006","unstructured":"Origer A: L'\u00e9tat du ph\u00e9nom\u00e8ne de la drogue au Grand-Duch\u00e9 de Luxembourg. R\u00e9seau National d'Information sur les Stup\u00e9fiants et les Toxicomanies (R.E.L.I.S). ed.2006. Luxembourg. . 2006, Point focal OEDT Luxembourg - CRP-Sant\u00e9"},{"key":"3180_CR12","unstructured":"Origer A, Schmit JC: Prevalence of hepatitis B and C and HIV infections among problem drug users in Luxembourg: self-report versus serological evidence. J Epidemiol Community Health."},{"key":"3180_CR13","volume-title":"Luxembourg: Centre de pr\u00e9vention des toxicomanies","author":"UC Fischer","year":"1999","unstructured":"Fischer UC, Krieger W: Suchtpr\u00e4ventioun an der Gemeng\". Entwicklung, Durchf\u00fchrung und Evaluation eines Modells zur gemeindeorientierten Suchtpr\u00e4vention. Luxembourg: Centre de pr\u00e9vention des toxicomanies. 1999"},{"issue":"8","key":"3180_CR14","doi-asserted-by":"publisher","first-page":"1237","DOI":"10.3748\/wjg.14.1237","volume":"14","author":"F Roman","year":"2008","unstructured":"Roman F, Hawotte K, Struck D, Ternes AM, Servais JY, Arendt V, Hoffman P, Hemmer R, Staub T, Seguin-Devaux C, et al: Hepatitis C virus genotypes distribution and transmission risk factors in Luxembourg from 1991 to 2006. World J Gastroenterol. 2008, 14 (8): 1237-1243. 10.3748\/wjg.14.1237.","journal-title":"World J Gastroenterol"},{"key":"3180_CR15","volume-title":"Study on HCV, HBV and HIV seroprevalence in a sample of drug users in contact with treatment centres or in prisons in Belgium","author":"S Plasschaert","year":"2004","unstructured":"Plasschaert S, Ameye L, De Clercq T: Study on HCV, HBV and HIV seroprevalence in a sample of drug users in contact with treatment centres or in prisons in Belgium. 2004"},{"issue":"4","key":"3180_CR16","first-page":"861","volume":"22","author":"ML Oliveira","year":"2006","unstructured":"Oliveira ML, Hacker MA, Oliveira SA, Telles PR, O KM, Yoshida CF, Bastos FI: \"The first shot\": the context of first injection of illicit drugs, ongoing injecting practices, and hepatitis C infection in Rio de Janeiro, Brazil. Cadernos de saude publica\/Ministerio da Saude, Fundacao Oswaldo Cruz, Escola Nacional de Saude Publica. 2006, 22 (4): 861-870.","journal-title":"Cadernos de saude publica\/Ministerio da Saude, Fundacao Oswaldo Cruz, Escola Nacional de Saude Publica"},{"issue":"3","key":"3180_CR17","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1016\/j.cld.2005.05.003","volume":"9","author":"DL Thomas","year":"2005","unstructured":"Thomas DL, Seeff LB: Natural history of hepatitis C. Clinics in liver disease. 2005, 9 (3): 383-398. 10.1016\/j.cld.2005.05.003. vi","journal-title":"Clinics in liver disease"},{"issue":"2","key":"3180_CR18","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1056\/NEJMoa066403","volume":"357","author":"ML Shiffman","year":"2007","unstructured":"Shiffman ML, Suter F, Bacon BR, Nelson D, Harley H, Sola R, Shafran SD, Barange K, Lin A, Soman A, et al: Peginterferon alfa-2a and ribavirin for 16 or 24 weeks in HCV genotype 2 or 3. N Engl J Med. 2007, 357 (2): 124-134. 10.1056\/NEJMoa066403.","journal-title":"N Engl J Med"},{"key":"3180_CR19","unstructured":"European Monitoring Centre for Drugs and Drug Addiction. [ http:\/\/www.emcdda.europa.eu\/stats10\/inftab3 ]"},{"issue":"2","key":"3180_CR20","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/j.drugalcdep.2006.01.009","volume":"84","author":"M Backmund","year":"2006","unstructured":"Backmund M, Meyer K, Schuetz C, Reimer J: Factors associated with exposure to hepatitis B virus in injection drug users. Drug and alcohol dependence. 2006, 84 (2): 154-159. 10.1016\/j.drugalcdep.2006.01.009.","journal-title":"Drug and alcohol dependence"},{"issue":"2","key":"3180_CR21","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1258\/095646206775455685","volume":"17","author":"A Clarke","year":"2006","unstructured":"Clarke A, Kulasegaram R: Hepatitis C transmission - where are we now?. International journal of STD & AIDS. 2006, 17 (2): 74-80. 10.1258\/095646206775455685. quiz 80","journal-title":"International journal of STD & AIDS"},{"issue":"3","key":"3180_CR22","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1159\/000130415","volume":"14","author":"F Vallejo","year":"2008","unstructured":"Vallejo F, Toro C, de la Fuente L, Brugal MT, Soriano V, Silva TC, Bravo MJ, Ballesta R, Barrio G: Prevalence of and risk factors for hepatitis B virus infection among street-recruited young injection and non-injection heroin users in Barcelona, Madrid and Seville. European addiction research. 2008, 14 (3): 116-124. 10.1159\/000130415.","journal-title":"European addiction research"},{"issue":"11","key":"3180_CR23","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.1097\/00002030-200107270-00002","volume":"15","author":"DR Gibson","year":"2001","unstructured":"Gibson DR, Flynn NM, Perales D: Effectiveness of syringe exchange programs in reducing HIV risk behavior and HIV seroconversion among injecting drug users. AIDS (London, England). 2001, 15 (11): 1329-1341. 10.1097\/00002030-200107270-00002.","journal-title":"AIDS (London, England)"},{"issue":"12","key":"3180_CR24","doi-asserted-by":"crossref","first-page":"3274","DOI":"10.1128\/JCM.35.12.3274-3277.1997","volume":"35","author":"SA Villano","year":"1997","unstructured":"Villano SA, Vlahov D, Nelson KE, Lyles CM, Cohn S, Thomas DL: Incidence and risk factors for hepatitis C among injection drug users in Baltimore, Maryland. Journal of clinical microbiology. 1997, 35 (12): 3274-3277.","journal-title":"Journal of clinical microbiology"},{"issue":"7","key":"3180_CR25","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1056\/NEJM199502163320707","volume":"332","author":"JL Gerberding","year":"1995","unstructured":"Gerberding JL: Management of occupational exposures to blood-borne viruses. N Engl J Med. 1995, 332 (7): 444-451. 10.1056\/NEJM199502163320707.","journal-title":"N Engl J Med"},{"key":"3180_CR26","volume-title":"Luxembourg: Comit\u00e9 de surveillance du SIDA","author":"Cdsd SIDA","year":"2010","unstructured":"SIDA Cdsd: Rapport D'activit\u00e9 2009. Luxembourg: Comit\u00e9 de surveillance du SIDA. 2010"},{"issue":"1","key":"3180_CR27","doi-asserted-by":"publisher","first-page":"42","DOI":"10.2105\/AJPH.91.1.42","volume":"91","author":"H Hagan","year":"2001","unstructured":"Hagan H, Thiede H, Weiss NS, Hopkins SG, Duchin JS, Alexander ER: Sharing of drug preparation equipment as a risk factor for hepatitis C. American journal of public health. 2001, 91 (1): 42-46.","journal-title":"American journal of public health"},{"issue":"7","key":"3180_CR28","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1093\/aje\/155.7.645","volume":"155","author":"LE Thorpe","year":"2002","unstructured":"Thorpe LE, Ouellet LJ, Hershow R, Bailey SL, Williams IT, Williamson J, Monterroso ER, Garfein RS: Risk of hepatitis C virus infection among young adult injection drug users who share injection equipment. Am J Epidemiol. 2002, 155 (7): 645-653. 10.1093\/aje\/155.7.645.","journal-title":"Am J Epidemiol"},{"key":"3180_CR29","volume-title":"Oral presentation on the European expert meeting on key indicator Drug Related Infectious Diseases","author":"Center for Disease Control","year":"2003","unstructured":"Center for Disease Control: Oral presentation on the European expert meeting on key indicator Drug Related Infectious Diseases. . 2003, EMCDDA-Lisbon, Oct 20-21"},{"key":"3180_CR30","doi-asserted-by":"crossref","unstructured":"Rosinska M: Current trends in HIV\/ AIDS epidemiology in Poland, 1999 - 2004. Euro Surveill. 2006, 11 (4):","DOI":"10.2807\/esm.11.04.00618-en"},{"key":"3180_CR31","doi-asserted-by":"crossref","unstructured":"Wiessing L, Guarita B, Giraudon I, Brummer-Korvenkontio H, Salminen M, Cowan SA: European monitoring of notifications of hepatitis C virus infection in the general population and among injecting drug users (IDUs) - the need to improve quality and comparability. Euro Surveill. 2008, 13 (21):","DOI":"10.2807\/ese.13.21.18884-en"}],"container-title":["BMC Public Health"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1471-2458-11-351\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2458-11-351.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2458-11-351","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2458-11-351.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,6,19]],"date-time":"2020-06-19T09:43:08Z","timestamp":1592559788000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpublichealth.biomedcentral.com\/articles\/10.1186\/1471-2458-11-351"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,5,19]]},"references-count":31,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011,12]]}},"alternative-id":["3180"],"URL":"https:\/\/doi.org\/10.1186\/1471-2458-11-351","relation":{},"ISSN":["1471-2458"],"issn-type":[{"value":"1471-2458","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,5,19]]},"article-number":"351"}}